Ameliorating Effects of chrysanthemum Against Capecitabin in Albino Rats

Document Type : Original Article

Authors

1 Veterinary Medicine Directorate, North Sinai Governorate

2 Department of Bacteriology, Mycology and Immunity, Faculty of Veterinary Medicine, Suez Canal University

3 Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Suez Canal University

Abstract

Our study was carried out to evaluate the effect of Chrysanthemum ethanolic extract on some hematological parameters in the anticancer drug capecitabine (XELODA®) exposed male rats using comet assay and biochemical changes. Thirty-six albino rats were divided into 6 groups (6 animals each) as follows:1) capecitabine group (xeloda at a dose of 30 mg/kg bw as a positive control); 2) capecitabine + chrysanthemum 5 mg/kg); 3) capecitabine (Xeloda) + Chrysanthemum (10 mg/kg); 4) Chrysanthemum (5 mg/kg) 5) Chrysanthemum (10 mg/kg); 6) Control group (negative control) for 45 days. The results of this study led to the following: capecitabine (Xeloda)treatment induces a decrease in RBCS, leukocytes, and platelets count, level of Hgb and Hct, while the use of capecitabine (Xeloda)in combination with Chrysanthemum improved these alterations, especially with the high dose of Chrysanthemum. Finally, the data suggest that the synchronous use of Chrysanthemum with capecitabine (Xeloda) treatment will be useful to decrease the side effects of capecitabine.

Keywords

Main Subjects

Files

Share

How to cite

Statistics